EIP cyclists Pedal4Cancer

No items found.
​
10 September 2018
Tags
No items found.
Table of contents
  • Toc Heading
  • Toc Heading

On 16 August, four of EIP’s most talented cyclists will be taking on the challenge of cycling from London to Cambridge, raising money for Target Ovarian Cancer. Partner, Gary Moss, will lead the team over a distance of 100km in the Pedal4Cancer event.

Target Ovarian Cancer is a charity that works to improve early diagnosis, fund life-saving research and provide much-needed support to women with ovarian cancer.

To find out more about this amazing charity and the incredible work they do, visit their website here. To sponsor Gary and his team by donating to Target Ovarian Cancer, visit Gary’s Just Giving page, here.

Related articles

See all articles

EIP appoints Catherine Howell as Partner, marking the firm’s first home‑grown litigation partner
05 March 2026
EIP is pleased to announce the promotion of Catherine Howell to Partner, marking a significant milestone as she becomes the firm’s first home‑grown litigation partner. Catherine joined EIP as a Trainee Solicitor in 2015 and has progressed through every stage of the firm’s litigation practice, most recently serving as Managing Associate.
​
EIP welcomes Anders Hansson as Partner to further strengthen our digital practice
19 January 2026
EIP is pleased to welcome Anders Hansson as Partner, bringing nearly 20 years of experience in AI, robotics, digital technologies, and European patent strategy. His industry and private‑practice background further strengthens our digital and high‑tech capabilities across Europe.
​
EIP Recognised in The Times Best Law Firms 2026
03 December 2025
EIP is proud to be featured in The Times Best Law Firms 2026, a prestigious list based on peer recommendations across the legal industry. This recognition highlights EIP’s commitment to technical excellence, client-focused service, and innovative IP strategies. From high-value patent litigation to strategic portfolio management, EIP continues to deliver results that matter for clients in technology, life sciences, and engineering. This accolade reinforces our position as a trusted leader in intellectual property law.
​